Signal active
Organization
Contact Information
Overview
Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
About
Biotechnology, Health Care, Pharmaceutical, Fitness
2018
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Magnitude Biosciences headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Fitness sector. The company focuses on Biotechnology and has secured $96.2M in funding across 80 round(s). With a team of 11-50 employees, Magnitude Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Magnitude Biosciences, raised $591.9K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
4
0
$1.2M
Details
4
Magnitude Biosciences has raised a total of $1.2M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Seed | 194.7K | ||
2019 | Seed | 291.1K | ||
2020 | Seed | 125.0K | ||
2022 | Seed |
Investors
Magnitude Biosciences is funded by 13 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
North East Innovation Fund | - | FUNDING ROUND - North East Innovation Fund | 591.9K |
Northstar Ventures | - | FUNDING ROUND - Northstar Ventures | 591.9K |
Magnitude Biosciences | - | FUNDING ROUND - Magnitude Biosciences | 591.9K |
Saker Capital | - | FUNDING ROUND - Saker Capital | 591.9K |
Recent Activity
There is no recent news or activity for this profile.